NCT05070494Unknown4 期
Efficacy of Different Doses of Influenza Vaccine in Chronic Hemodialysis Patients: Randomized Controlled Trial (Enhance Study)
适应症
试验速览
- 阶段
- 4 期
- 入组人数
- 175
- 试验地点
- 2
- 主要终点
- To compare proportion of seroprotection of different doses of influenza vaccine in hemodialysis patients at month 12
研究概览
简要总结
This study was a randomized controlled trial to investigate the immune response of influenza vaccines when doses were increased. and a second vaccination together with an increase in the amount of vaccine in patients with chronic kidney disease receiving hemodialysis
详细描述
- Patients with chronic kidney disease undergoing dialysis will be examined by an internist.
- Collect the necessary basic information of patients who agree to participate in the treatment.
- Patients will be randomized to be divided into 3 groups: those who will receive an standard dose of influenza vaccine, those who will receive double standard dose of influenza vaccine (double-dose) and those who will receive double standard dose of influenza vaccine and Six months after the first dose of vaccination (double-booster-dose), 50 people per group.
- Non-dialysis volunteers will be invited to participate in the research. to be a control group of 25 people
- Patients with chronic kidney disease and volunteers will receive basic laboratory blood tests.
- Patients with chronic kidney disease and volunteers will be vaccinated against influenza. shoulder muscle area according to random groups The details of using Influvac vaccine of that year are produced by Abbott.
- Patients with chronic kidney disease and volunteers are asked about the potential side effects of vaccination. according to research guidelines both systemic side effects and injection site Each time receiving hemodialysis 3 times a week for 2 weeks after vaccination
- Patients with chronic kidney disease and volunteers were asked about the onset of symptoms of respiratory infection throughout the 12-month study period after vaccination.
- Patients will receive a blood test to check their immune response to influenza vaccine. (Hemagglutination inhibition assays and activation and/or exhaustion T cell markers, T cell subpopulation by flow cytometry) at 1, 6, 7 and 12 months after influenza vaccination.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Age ≥18 years
- •Received kidney replacement therapy with dialysis for more than 1 month.
- •Hemodialysis at least 3 times a week
- •(Kt/v) greater than 1.2
- •Never received an organ transplant.
- •Life expectancy of more than 1 year
- •Research participants or representatives are welcome to join the project by signing.
排除标准
- •History of any vaccinations in the 4 weeks prior to the study.
- •History of receiving influenza vaccine 6 months before entering this study.
- •History of allergy to flu vaccine or allergic to egg white
- •Fever or headache, muscle pain (influenza-like illness) 3 days before vaccination
- •Thrombocytopenia
- •On immunosuppressive drug (Prednisolone 15 mg daily or equivalent for two weeks in a row in the previous 3 months) or immunocompromised patient
- •Patient or family history of having had Guillain-Barre disease. (Guillain-Barre syndrome)
- •The research participant or his representative refuses or requests to withdraw.
结局指标
主要结局
To compare proportion of seroprotection of different doses of influenza vaccine in hemodialysis patients at month 12
时间窗: 12 months
Patients will receive a blood test to check their immune response to influenza vaccine. (Hemagglutination inhibition assays and activation and/or exhaustion T cell markers, T cell subpopulation by flow cytometry) at month 12 after influenza vaccination.
次要结局
- To compare the prevention of influenza virus infection in different doses of influenza vaccination.(12 months of data collection)
研究者
Angsana Phuphuakrat
Angsana Phuphuakrat
Mahidol University
研究点 (2)
Loading locations...
相似试验
已完成
4 期
Immunologic Response to FluMist vs. FlucelvaxInfluenza, HumanImmune ResponseNCT03982069Richard Zimmerman MD465
已完成
4 期
Immunologic Response to Influenza Vaccination in Children and AdolescentsInfluenza, HumanImmune ResponseNCT03614975Richard Zimmerman MD166
已完成
1 期
A Dose Ranging Study Comparing Different Combinations of Adjuvanted and Non-adjuvanted Influenza Vaccines in Healthy Children 6 to <36 Months of AgeInfluenzaNCT00848887Novartis410
已完成
不适用
Immune Response to Influenza VaccinationSolid Organ TransplantationChronic Kidney DiseaseNCT00551837The Cleveland Clinic82
已完成
3 期
Comparative Study of Immunogenicity and Safety of Flu-ID Vaccine Versus Flu-IM VaccineInfluenzaNCT00554333Sanofi Pasteur, a Sanofi Company795